Cargando…
The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a high-mortality malignant tumor with genetic and phenotypic heterogeneity, making predicting clinical outcomes challenging. The purpose of this investigation was to examine the potential usefulness of lncRNA DDX11 antisense RNA 1 (DDX11-AS1) as a biomarker for diag...
Autores principales: | Luo, Xiaojun, Wang, Yang, Zhang, Xi, Liu, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444391/ https://www.ncbi.nlm.nih.gov/pubmed/36072974 http://dx.doi.org/10.1155/2022/5735462 |
Ejemplares similares
-
Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Zhi-kun, et al.
Publicado: (2017) -
Serum long noncoding RNA LRB1 as a potential biomarker for predicting the diagnosis and prognosis of human hepatocellular carcinoma
por: Wang, Zhi-Feng, et al.
Publicado: (2018) -
DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma
por: Shi, Min, et al.
Publicado: (2017) -
Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022) -
An angiogenesis‐related long noncoding RNA signature correlates with prognosis in patients with hepatocellular carcinoma
por: Lei, Dengliang, et al.
Publicado: (2021)